Poland· PL-100370455

Imupret N

A medicinal product containing produkt ziołowy, registered in Poland by Bionorica SE.

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedImupret NATC—REGISTER NO.PL-100370455PACKS LISTED2CHECKEDSeptember 27, 2026

The record

At a glance

URPL (Poland)
Active substance
Produkt ziołowy
Manufacturer
Bionorica SE
Country
Poland (PL)
ATC code
—
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 2

  • gtin
    05909991304072
  • gtin
    05909991304089

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/6e324100-26c4-461d-88f3-746848f24688
GET /v1/drugs/6e324100-26c4-461d-88f3-746848f24688?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Krople doustne",
  "source": "urpl",
  "strength": "1 ml/ml",
  "packaging": "05909991304072 ¦ OTC ¦ 118858\n1 op. 50 ml\n05909991304089 ¦ OTC ¦ 118859\n1 op. 100 ml",
  "substance": "Extractum compositum (1:38) ex: Equiseti herba, Millefolii herba, Altheae radice, Juglandis folio, Taraxaci herba, Matricariae flore, Quercus cortice 100 g",
  "common_name": "Produkt ziołowy",
  "pl_product_id": "100370455",
  "pozwolenie_nr": "23554",
  "auth_procedure": "NAR",
  "authorisation_validity": "Bezterminowe"
}

See everything about produkt ziołowy.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.